These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 25866058)

  • 21. [Malignant melanoma and the role of the paradoxal protein Microphthalmia transcription factor].
    Denat L; Larue L
    Bull Cancer; 2007 Jan; 94(1):81-92. PubMed ID: 17237008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phosphatidylinositol 3-kinase-Pax3 axis regulates Brn-2 expression in melanoma.
    Bonvin E; Falletta P; Shaw H; Delmas V; Goding CR
    Mol Cell Biol; 2012 Nov; 32(22):4674-83. PubMed ID: 22988297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ERK-regulated differential expression of the Mitf 6a/b splicing isoforms in melanoma.
    Primot A; Mogha A; Corre S; Roberts K; Debbache J; Adamski H; Dreno B; Khammari A; Lesimple T; Mereau A; Goding CR; Galibert MD
    Pigment Cell Melanoma Res; 2010 Feb; 23(1):93-102. PubMed ID: 19895547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical role of glioma-associated oncogene homolog 1 in maintaining invasive and mesenchymal-like properties of melanoma cells.
    Gunarta IK; Li R; Nakazato R; Suzuki R; Boldbaatar J; Suzuki T; Yoshioka K
    Cancer Sci; 2017 Aug; 108(8):1602-1611. PubMed ID: 28635133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines.
    Noguchi K; Dalton AC; Howley BV; McCall BJ; Yoshida A; Diehl JA; Howe PH
    PLoS One; 2017; 12(5):e0177830. PubMed ID: 28545079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of MITF and other melanosome-related proteins with chemoresistance in melanoma tumors and cell lines.
    Hertzman Johansson C; Azimi A; Frostvik Stolt M; Shojaee S; Wiberg H; Grafström E; Hansson J; Egyházi Brage S
    Melanoma Res; 2013 Oct; 23(5):360-5. PubMed ID: 23921446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MITF, the Janus transcription factor of melanoma.
    Koludrovic D; Davidson I
    Future Oncol; 2013 Feb; 9(2):235-44. PubMed ID: 23414473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SOX2 modulates levels of MITF in normal human melanocytes, and melanoma lines in vitro.
    Cimadamore F; Shah M; Amador-Arjona A; Navarro-Peran E; Chen C; Huang CT; Terskikh AV
    Pigment Cell Melanoma Res; 2012 Jul; 25(4):533-6. PubMed ID: 22571403
    [No Abstract]   [Full Text] [Related]  

  • 29. KIT
    Phung B; Kazi JU; Lundby A; Bergsteinsdottir K; Sun J; Goding CR; Jönsson G; Olsen JV; Steingrímsson E; Rönnstrand L
    Mol Cancer Res; 2017 Sep; 15(9):1265-1274. PubMed ID: 28584020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions of Melanoma Cells with Distal Keratinocytes Trigger Metastasis via Notch Signaling Inhibition of MITF.
    Golan T; Messer AR; Amitai-Lange A; Melamed Z; Ohana R; Bell RE; Kapitansky O; Lerman G; Greenberger S; Khaled M; Amar N; Albrengues J; Gaggioli C; Gonen P; Tabach Y; Sprinzak D; Shalom-Feuerstein R; Levy C
    Mol Cell; 2015 Aug; 59(4):664-76. PubMed ID: 26236014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy.
    Wellbrock C; Arozarena I
    Pigment Cell Melanoma Res; 2015 Jul; 28(4):390-406. PubMed ID: 25818589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of microphthalmia-associated transcription factor (MITF), which is critical for melanoma progression, is inhibited by both transcription factor GLI2 and transforming growth factor-β.
    Pierrat MJ; Marsaud V; Mauviel A; Javelaud D
    J Biol Chem; 2012 May; 287(22):17996-8004. PubMed ID: 22496449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer suppressor candidate-1 (BCSC-1) is a melanoma tumor suppressor that down regulates MITF.
    Anghel SI; Correa-Rocha R; Budinska E; Boligan KF; Abraham S; Colombetti S; Fontao L; Mariotti A; Rimoldi D; Ghanem GE; Fisher DE; Lévy F; Delorenzi M; Piguet V
    Pigment Cell Melanoma Res; 2012 Jul; 25(4):482-7. PubMed ID: 22594792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The roles of microphthalmia-associated transcription factor and pigmentation in melanoma.
    Hsiao JJ; Fisher DE
    Arch Biochem Biophys; 2014 Dec; 563():28-34. PubMed ID: 25111671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny.
    Cheli Y; Giuliano S; Botton T; Rocchi S; Hofman V; Hofman P; Bahadoran P; Bertolotto C; Ballotti R
    Oncogene; 2011 May; 30(20):2307-18. PubMed ID: 21278797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A conditional zebrafish MITF mutation reveals MITF levels are critical for melanoma promotion vs. regression in vivo.
    Lister JA; Capper A; Zeng Z; Mathers ME; Richardson J; Paranthaman K; Jackson IJ; Elizabeth Patton E
    J Invest Dermatol; 2014 Jan; 134(1):133-140. PubMed ID: 23831555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide analysis of POU3F2/BRN2 promoter occupancy in human melanoma cells reveals Kitl as a novel regulated target gene.
    Kobi D; Steunou AL; Dembélé D; Legras S; Larue L; Nieto L; Davidson I
    Pigment Cell Melanoma Res; 2010 Jun; 23(3):404-18. PubMed ID: 20337985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel hypoxia-associated subset of FN1 high MITF low melanoma cells: identification, characterization, and prognostic value.
    Wouters J; Stas M; Govaere O; Barrette K; Dudek A; Vankelecom H; Haydu LE; Thompson JF; Scolyer RA; van den Oord JJ
    Mod Pathol; 2014 Aug; 27(8):1088-100. PubMed ID: 24390218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cooperative antiproliferative signaling by aspirin and indole-3-carbinol targets microphthalmia-associated transcription factor gene expression and promoter activity in human melanoma cells.
    Poindexter KM; Matthew S; Aronchik I; Firestone GL
    Cell Biol Toxicol; 2016 Apr; 32(2):103-19. PubMed ID: 27055402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BRN2 and MITF together impact AXL expression in melanoma.
    Simmons JL; Neuendorf HM; Boyle GM
    Exp Dermatol; 2022 Jan; 31(1):89-93. PubMed ID: 33119145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.